Ginger, a Possible Candidate for the Treatment of Dementias?

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2021 Sep 28

PMID 34577171

Citations 8

Authors

Giovanni Schepici

Valentina Contestabile

Andrea Valeri

Emanuela Mazzon

Affiliations

Soon will be listed here.

Abstract

As the human life expectancy increases, age-linked diseases have become more and more frequent. The worldwide increment of dementia cases demands medical solutions, but the current available drugs do not meet all the expectations. Recently the attention of the scientific community was attracted by natural compounds, used in ancient medicine, known for their beneficial effects and high tolerability. This review is focused on Ginger () and explore its properties against Alzheimer's Disease and Vascular Dementia, two of the most common and devastating forms of dementia. This work resumes the beneficial effects of Ginger compounds, tested in computational in vitro and in vivo models of Alzheimer's Disease and Vascular Dementia, along with some human tests. All these evidences suggest a potential role of the compounds of ginger not only in the treatment of the disease, but also in its prevention.

Citing Articles

Effects of ginger root extract on cognitive impairment and the Nrf2/GPX4/SLC7A11 signaling pathway in aluminum-exposed rats.

Qin L, Jiang X, Wei Y, Xie J, Yang L Metab Brain Dis. 2024; 40(1):60.

PMID: 39661217 DOI: 10.1007/s11011-024-01495-5.

Effects of Ginger () on the Hallmarks of Aging.

Matin M, Joshi T, Wang D, Tzvetkov N, Matin F, Wierzbicka A Biomolecules. 2024; 14(8).

PMID: 39199328 PMC: 11352747. DOI: 10.3390/biom14080940.

Nutritional aphrodisiacs: Biochemistry and Pharmacology.

Al-Madhagi H, Tarabishi A Curr Res Food Sci. 2024; 9:100783.

PMID: 38974844 PMC: 11225857. DOI: 10.1016/j.crfs.2024.100783.

Extraction, Purification, Structural Characteristics, Biological Activities, and Applications of the Polysaccharides from Roscoe. (Ginger): A Review.

Hu W, Yu A, Wang S, Bai Q, Tang H, Yang B Molecules. 2023; 28(9).

PMID: 37175266 PMC: 10179780. DOI: 10.3390/molecules28093855.

A Review on Phyto-Therapeutic Approaches in Alzheimer's Disease.

Sahiner M, Yilmaz A, Gungor B, Sahiner N J Funct Biomater. 2023; 14(1).

PMID: 36662097 PMC: 9861153. DOI: 10.3390/jfb14010050.

References

Pagano E, Souto E, Durazzo A, Sharifi-Rad J, Lucarini M, Souto S . Ginger (Zingiber officinale Roscoe) as a nutraceutical: Focus on the metabolic, analgesic, and antiinflammatory effects. Phytother Res. 2020; 35(5):2403-2417. DOI: 10.1002/ptr.6964. View

Palachai N, Wattanathorn J, Muchimapura S, Thukham-Mee W . Phytosome Loading the Combined Extract of Mulberry Fruit and Ginger Protects against Cerebral Ischemia in Metabolic Syndrome Rats. Oxid Med Cell Longev. 2020; 2020:5305437. PMC: 7397413. DOI: 10.1155/2020/5305437. View

Kim D, Kim J, Han Y . Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult. J Altern Complement Med. 2007; 13(3):333-40. DOI: 10.1089/acm.2006.6107. View

El Halawany A, Sayed N, Abdallah H, El Dine R . Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer's disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta - secretases and APH1a. Sci Rep. 2017; 7(1):2902. PMC: 5460182. DOI: 10.1038/s41598-017-02961-0. View

Lima R, Dos Reis A, de Menezes A, de Oliveira Santos J, Oliveira Filho J, Ferreira J . Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]-gingerol in cancer: A comprehensive review. Phytother Res. 2018; 32(10):1885-1907. DOI: 10.1002/ptr.6134. View

Aarsland D . Epidemiology and Pathophysiology of Dementia-Related Psychosis. J Clin Psychiatry. 2020; 81(5). DOI: 10.4088/JCP.AD19038BR1C. View

Faraci F . Reactive oxygen species: influence on cerebral vascular tone. J Appl Physiol (1985). 2006; 100(2):739-43. DOI: 10.1152/japplphysiol.01044.2005. View

Libro R, Giacoppo S, Rajan T, Bramanti P, Mazzon E . Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview. Molecules. 2016; 21(4):518. PMC: 6274085. DOI: 10.3390/molecules21040518. View

Nagendra chari K, Manasa D, Srinivas P, Sowbhagya H . Enzyme-assisted extraction of bioactive compounds from ginger (Zingiber officinale Roscoe). Food Chem. 2013; 139(1-4):509-14. DOI: 10.1016/j.foodchem.2013.01.099. View

10.

Sutalangka C, Wattanathorn J . Neuroprotective and cognitive-enhancing effects of the combined extract of Cyperus rotundus and Zingiber officinale. BMC Complement Altern Med. 2017; 17(1):135. PMC: 5335841. DOI: 10.1186/s12906-017-1632-4. View

11.

Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

12.

Wang H, Wang L, Zhang N, Zhang Q, Zhao H, Zhang Q . Houshiheisan compound prescription protects neurovascular units after cerebral ischemia. Neural Regen Res. 2014; 9(7):741-8. PMC: 4146281. DOI: 10.4103/1673-5374.131580. View

13.

Lindwall G, Cole R . Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem. 1984; 259(8):5301-5. View

14.

Gale S, Acar D, Daffner K . Dementia. Am J Med. 2018; 131(10):1161-1169. DOI: 10.1016/j.amjmed.2018.01.022. View

15.

Iqbal K, Grundke-Iqbal I . Alzheimer's disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement. 2010; 6(5):420-4. PMC: 2946155. DOI: 10.1016/j.jalz.2010.04.006. View

16.

Grzanna R, Lindmark L, Frondoza C . Ginger--an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005; 8(2):125-32. DOI: 10.1089/jmf.2005.8.125. View

17.

Mizuno D, Konoha-Mizuno K, Mori M, Yamazaki K, Haneda T, Koyama H . An In Vitro System Comprising Immortalized Hypothalamic Neuronal Cells (GT1-7 Cells) for Evaluation of the Neuroendocrine Effects of Essential Oils. Evid Based Complement Alternat Med. 2015; 2015:343942. PMC: 4631885. DOI: 10.1155/2015/343942. View

18.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

19.

Soria Lopez J, Gonzalez H, Leger G . Alzheimer's disease. Handb Clin Neurol. 2019; 167:231-255. DOI: 10.1016/B978-0-12-804766-8.00013-3. View

20.

Afzal M, Menon M, Pesek J, Dhami M . Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol Drug Interact. 2002; 18(3-4):159-90. DOI: 10.1515/dmdi.2001.18.3-4.159. View